IBB.MX iShares Trust - iShares Biotechnology ETF
- Total assets
- 205B
- Expense ratio
- 0.44%
- Dividend yield
- 0.58%
- 1-year return
- +36.00%
- Holdings
- 10
- Since
- 2001
Fund data as reported by the issuer, updated Nov 7, 2026. Total assets are in the fund's base currency.
What does IBB.MX invest in?
Tracks Morningstar US Health TR USD- Mostly US stocks (94.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (91.1%)
- Top 3 holdings: 24.6% of the fund
Asset allocation
- US stocks 94.4%
- Non-US stocks 5.2%
- Cash 0.1%
Top holdings
- Gilead Sciences Inc 8.57%
- Amgen Inc 8.44%
- Vertex Pharmaceuticals Inc 7.57%
- Regeneron Pharmaceuticals Inc 6.32%
- Moderna Inc 5.40%
iShares Trust - iShares Biotechnology ETF performance
Sharpe ratio 0.86- This year
- +33.23%
- 1 year
- +36.00%
- 3 years
- +24.42%
- 5 years
- +4.76%
Volatility 16.4% over 1 year and 19.1% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
IBB.MX price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About iShares Trust - iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Full fund profileiShares Trust - iShares Biotechnology ETF top holdings
50.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Gilead Sciences Inc GILD.US | Healthcare | United States | 8.57% |
| Amgen Inc AMGN.US | Healthcare | United States | 8.44% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 7.57% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 6.32% |
| Moderna Inc MRNA.US | Healthcare | United States | 5.40% |
| Natera Inc NTRA.US | Healthcare | United States | 3.77% |
| argenx NV ADR ARGX.US | Healthcare | United States | 3.33% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 2.58% |
| Illumina Inc ILMN.US | Healthcare | United States | 2.47% |
| Biogen Inc BIIB.US | Healthcare | United States | 2.46% |
IBB.MX sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
IBB.MX regional exposure
- North America91.1%
- Europe Developed2.8%
- United Kingdom1.7%
- Asia Emerging0.1%
- Asia Developed0.1%
- Australasia0.1%
Share of the stocks in the fund.
Company size
Average market cap 648B- Big cap36.3%
- Medium cap34.5%
- Small cap21.0%
- Micro cap8.5%
iShares Trust - iShares Biotechnology ETF fund profile
- Fund name
- iShares Trust - iShares Biotechnology ETF
- Ticker
- IBB.MX
- Exchange
- Mexican Exchange
- Issuer
- iShares
- Index tracked
- Morningstar US Health TR USD
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Feb 5, 2001
- Trading currency
- MXN
- Expense ratio
- 0.44%
- Annual turnover
- 0.1%
About iShares Trust - iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.